Archive for Cabazitaxel
UroToday.com published a dual-center study today that confirms that carboplatin and paclitaxel (a taxane product) has an active effect on PSA when used in the treatment of men with castrate resistant prostate cancer (CRPC) after docetaxel (chemotherapy for prostate cancer). Read More→
Medicare/ Trailblazer Rejects Reimbursement for Provenge & Jevtana!
Posted by: | CommentsA member of the advanced prostate cancer on-line support group who is the wife of an advanced prostate cancer survivor in New Mexico just informed us that Trailblazer (the MAC that controls New Mexico reimbursements for Medicare and Medicaid) has said they will not pay for her husband to get Provenge. They were also told by their doctor that he can’t get Medicare/Trailblazer to pay for Jevtana even though he meets the FDA approved label for failed chemotherapy.
She posted: “Jevtana for prostate cancer, Medicare doesn’t want to pay for it. We also learned today that Provenge will not be covered by Medicare & we will have to pay cash for it.
Die or use up all your retirement savings.”
She is very upset as these were his last treatment options that have demonstrated any survival advantage.
Both Provenge and Jevtana have been approved by the FDA.
This is outrageous.
Joel T Nowak, M.A., M.S.W.
New Drug for Advanced Prostate Cancer
Posted by: | Comments
New Drug for Advanced Prostate Cancer
Can Our Society Find Its Way To An Honest Dialogue About The Price Of A Human Life?
Posted by: | CommentsWhat is the real cost of approved treatments for advanced prostate cancer and how much we should spend? These questions are rippling through the prostate cancer community and the general population. Read More→
Sanofi-aventis, the pharmaceutical company that makes taxotere and the newly approved drug, Jevtana (cabazitaxel) yesterday announced that their newly approved treatment for men with metastatic hormone-refractory prostate cancer (mHRPC) who have been previously treated with a docetaxel-based treatment regimen and failed is finally available for distribution in the United States. Around one month ago, Jevtana was approved by the U.S. Food and Drug Administration (FDA), but it has not been available. Read More→
